John Haluschak, MD
Medical Oncologist
Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma
Biological Therapy/Immunotherapy Chemotherapy Gene Therapy Pain Management Targeted Therapy
Loma Linda University School of Medicine
Medical School
Kettering Medical Center
Residency
Case Western Reserve University - University Hospitals
Fellowship
American Board of Internal Medicine - Oncology
OH State Medical License Active through 2018
Active Surveillance for the Management of Localized Prostate Cancer (Cancer Care Ontario Guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement.
Chen RC, Rumble RB, Loblaw DA, Finelli A, Ehdaie B, Cooperberg MR, Morgan SC, Tyldesley S, Haluschak JJ, Tan W, Justman S, Jain S; J. Clin. Oncol.. 2016-06-20.
See more >>Combined chemoradiotherapy regimens of paclitaxel and carboplatin for locally advanced non-small-cell lung cancer: a randomized phase II locally advanced multi-modality protocol.
Belani, C. P., Choy, H., Bonomi, P., Scott, C., Travis, P., Haluschak, J., Curran, W. J.; J Clin Oncol. 2005 Sep 1.
See more >>p53 mutations in bladder carcinoma cell lines.
Cooper, M. J., Haluschak, J. J., Johnson, D., Schwartz, S., Morrison, L. J., Lippa, M., Hatzivassiliou, G., Tan, J.; Oncol Res. 1994.
See more >>